\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ significant\\ physical\\ exam\\ findings\\.\ \(0\)\
\-\ surgical\\ resection\\ and\\ started\\ on\\ chemotherapy\ \(0\)\
\-\ focal\\ wall\\ thickening\\ \\(11mm\\)\\ of\\ a\\ segment\\ of\\ jejunum\\ in\\ the\\ left\\ upper\\ quadrant\\.\\ \\ this\\ segment\\ of\\ jejunum\\ is\\ also\\ dilated\\ with\\ a\\ maximum\\ diameter\\ of\\ 5\\.3\\ cm\\ with\\ retained\\ contrast\\ and\\ an\\ air\\-fluid\\ level\\.\\ \\ also\\ noted\\ is\\ surrounding\\ lymphadenopathy\\ and\\ peritoneal\\ fat\\ stranding\\,\\ the\\ largest\\ mesenteric\\ lymphnode\\ measuring\\ 1\\.3cm\\ in\\ its\\ shortest\\ diameter\\.\ \(0\)\
\-\ non\\-hodgkins\\ lymphoma\\ \\(large\\ b\\-cell\\)\\ of\\ the\\ proximal\\ small\\ bowel\ \(0\)\
\-\ \\<i\\>lymphoma\ \(0\)\
\-\ \\<i\\>adenocarcinoma\ \(0\)\
\-\ \\<i\\>carcinoid\\ tumor\ \(0\)\
\-\ \\<i\\>metastases\ \(0\)\
\-\ active\\ duty\\ soldier\\ with\\ three\\ week\\ history\\ of\\ nausea\\,\\ vomiting\\,\\ and\\ epigastric\\ abdominal\\ pain\\ while\\ deployed\\ in\\ iraq\\.\ \(0\)\
\-\ non\\-hodgkin\\ lymphoma\\ is\\ the\\ most\\ common\\ malignancy\\ of\\ the\\ small\\ bowel\\,\\ representing\\ 20\\%\\ of\\ small\\ bowel\\ malignancies\\.\\ \\ it\\ most\\ often\\ occurs\\ in\\ males\\ between\\ 50\\ to\\ 60\\ years\\ old\\ and\\ occurs\\ most\\ often\\ in\\ the\\ distal\\ ileum\\.\\ \\ prognosis\\ is\\ worse\\ for\\ younger\\ patients\\ and\\ females\\.\\ \\ \\ immunocompromised\\ patients\\ have\\ an\\ increased\\ frequency\\ of\\ non\\-hodgkin\\â\\€\\™s\\ lymphoma\\ of\\ the\\ small\\ bowel\\.\ \(0\)\
\-\ the\\ radiographic\\ appearance\\ of\\ small\\ bowel\\ varies\\ to\\ include\\ fold\\ thickening\\ or\\ effacement\\,\\ luminal\\ narrowing\\,\\ diffuse\\ nodularity\\,\\ extrinsic\\ compression\\ by\\ mesenteric\\ masses\\,\\ and\\ most\\ often\\ marked\\ luminal\\ dilatation\\.\\ \\ lymphoma\\ of\\ the\\ small\\ intestine\\ may\\ also\\ present\\ as\\ an\\ ulcerating\\ mass\\.\\ \\ diagnosis\\ of\\ primary\\ small\\ bowel\\ lymphoma\\ is\\ made\\ by\\ the\\ presence\\ of\\ an\\ isolated\\ small\\ bowel\\ lesion\\ and\\ regional\\ lymphadenopathy\\ without\\ splenic\\,\\ hematologic\\,\\ or\\ hepatic\\ involvment\\.\\ \\ \ \(0\)\
\-\ the\\ differential\\ diagnosis\\ of\\ non\\-hodgkin\\ includes\\ adenocarcinoma\\,\\ carcinoid\\ tumor\\,\\ gastrointestinal\\ stromal\\ tumor\\,\\ lipoma\\,\\ metastases\\,\\ and\\ peutz\\-jeghers\\ syndrome\\.\\ \\ imaging\\ modalities\\ include\\ fluoroscopy\\,\\ ct\\,\\ and\\ mri\\.\ \(0\)\
\-\ the\\ diagnosis\\ can\\ be\\ suggested\\ with\\ imaging\\ when\\ focal\\ thickening\\ of\\ a\\ bowel\\ loop\\ associated\\ with\\ \\"aneurysmal\\ dilatation\\"\\ of\\ the\\ segment\\ and\\ regional\\ lymphadenopathy\\ is\\ seen\\,\\ as\\ on\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bowel\\:\\ 0\\.06516604335282089\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.05179353381189072\ \(0\)\
\-\ small\\:\\ 0\\.047868092021425376\ \(0\)\
\-\ lymphoma\\:\\ 0\\.044538576918957185\ \(0\)\
\-\ i\\:\\ 0\\.04294607532192717\ \(0\)\
\-\ \\<\\:\\ 0\\.04009806112464183\ \(0\)\
\-\ jejunum\\:\\ 0\\.03569045255197604\ \(0\)\
\-\ luminal\\:\\ 0\\.03452902254126048\ \(0\)\
\-\ \\>\\:\\ 0\\.0345187539777333\ \(0\)\
\-\ segment\\:\\ 0\\.03399321053556943\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.03313436055022261\ \(0\)\
\-\ regional\\:\\ 0\\.032913805728293874\ \(0\)\
\-\ carcinoid\\:\\ 0\\.030868381797465833\ \(0\)\
\-\ shortest\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ thickening\\:\\ 0\\.026412989997203814\ \(0\)\
\-\ often\\:\\ 0\\.024861460928750627\ \(0\)\
\-\ ulcerating\\:\\ 0\\.024688058490597426\ \(0\)\
\-\ most\\:\\ 0\\.023985837589399102\ \(0\)\
\-\ mesenteric\\:\\ 0\\.023953319761491468\ \(0\)\
\-\ 11mm\\:\\ 0\\.02258122815454896\ \(0\)\
\-\ 1\\.3cm\\:\\ 0\\.02258122815454896\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.02244106045327197\ \(0\)\
\-\ dilatation\\:\\ 0\\.022262777078837198\ \(0\)\
\-\ metastases\\:\\ 0\\.022192902431872243\ \(0\)\
\-\ lymphnode\\:\\ 0\\.021902980278213975\ \(0\)\
\-\ non\\-hodgkins\\:\\ 0\\.021902980278213975\ \(0\)\
\-\ hematologic\\:\\ 0\\.021902980278213975\ \(0\)\
\-\ peutz\\-jeghers\\:\\ 0\\.021902980278213975\ \(0\)\
\-\ diameter\\:\\ 0\\.021855091786554245\ \(0\)\
\-\ occurs\\:\\ 0\\.021320673109819412\ \(0\)\
\-\ involvment\\:\\ 0\\.02011639467060875\ \(0\)\
\-\ 5\\.3\\:\\ 0\\.019506453347015586\ \(0\)\
\-\ iraq\\:\\ 0\\.019241981076530388\ \(0\)\
\-\ intestine\\:\\ 0\\.01877343797675149\ \(0\)\
\-\ immunocompromised\\:\\ 0\\.018563733200195404\ \(0\)\
\-\ tumor\\:\\ 0\\.018166251990372136\ \(0\)\
\-\ diagnosis\\:\\ 0\\.017892577484319938\ \(0\)\
\-\ fold\\:\\ 0\\.01726451127063024\ \(0\)\
\-\ deployed\\:\\ 0\\.01713515074048192\ \(0\)\
\-\ varies\\:\\ 0\\.01701107172978206\ \(0\)\
\-\ retained\\:\\ 0\\.016559947094164206\ \(0\)\
\-\ malignancies\\:\\ 0\\.016559947094164206\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.016559947094164206\ \(0\)\
\-\ soldier\\:\\ 0\\.01635723774918344\ \(0\)\
\-\ nodularity\\:\\ 0\\.01635723774918344\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.016167206268997016\ \(0\)\
\-\ stromal\\:\\ 0\\.016167206268997016\ \(0\)\
\-\ extrinsic\\:\\ 0\\.015988359764368038\ \(0\)\
\-\ air\\-fluid\\:\\ 0\\.015659443093729034\ \(0\)\
\-\ modalities\\:\\ 0\\.015582489270068577\ \(0\)\
\-\ maximum\\:\\ 0\\.015434190898732917\ \(0\)\
\-\ also\\:\\ 0\\.015361272890609281\ \(0\)\
\-\ epigastric\\:\\ 0\\.015224486122176835\ \(0\)\
\-\ younger\\:\\ 0\\.015157680934581773\ \(0\)\
\-\ loop\\:\\ 0\\.015157680934581773\ \(0\)\
\-\ males\\:\\ 0\\.014965647798954016\ \(0\)\
\-\ focal\\:\\ 0\\.01483582738078056\ \(0\)\
\-\ \\,\\:\\ 0\\.014810885043499006\ \(0\)\
\-\ largest\\:\\ 0\\.014727132250499625\ \(0\)\
\-\ include\\:\\ 0\\.014572361629363446\ \(0\)\
\-\ ileum\\:\\ 0\\.014559777304654554\ \(0\)\
\-\ females\\:\\ 0\\.014453116758115742\ \(0\)\
\-\ an\\:\\ 0\\.014366746070331062\ \(0\)\
\-\ effacement\\:\\ 0\\.014250407413134974\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.014153906810355095\ \(0\)\
\-\ aneurysmal\\:\\ 0\\.014106781623315686\ \(0\)\
\-\ splenic\\:\\ 0\\.014060375932948548\ \(0\)\
\-\ frequency\\:\\ 0\\.013712624105660572\ \(0\)\
\-\ duty\\:\\ 0\\.013552612757680568\ \(0\)\
\-\ peritoneal\\:\\ 0\\.013513892314588076\ \(0\)\
\-\ isolated\\:\\ 0\\.013513892314588076\ \(0\)\
\-\ patients\\:\\ 0\\.013444222488547269\ \(0\)\
\-\ representing\\:\\ 0\\.013400605400310775\ \(0\)\
\-\ suggested\\:\\ 0\\.013220700016145637\ \(0\)\
\-\ stranding\\:\\ 0\\.012563486920493248\ \(0\)\
\-\ prognosis\\:\\ 0\\.012320196015710463\ \(0\)\
\-\ imaging\\:\\ 0\\.012170661546842569\ \(0\)\
\-\ lipoma\\:\\ 0\\.012143577077086508\ \(0\)\
\-\ started\\:\\ 0\\.011585325586690088\ \(0\)\
\-\ worse\\:\\ 0\\.01150480395919168\ \(0\)\
\-\ 60\\:\\ 0\\.011331070178523143\ \(0\)\
\-\ hepatic\\:\\ 0\\.010846487391507635\ \(0\)\
\-\ includes\\:\\ 0\\.010470761081577008\ \(0\)\
\-\ nausea\\:\\ 0\\.01045665658444478\ \(0\)\
\-\ narrowing\\:\\ 0\\.010414731593161086\ \(0\)\
\-\ measuring\\:\\ 0\\.010387099460330533\ \(0\)\
\-\ made\\:\\ 0\\.010346116632557623\ \(0\)\
\-\ is\\:\\ 0\\.01025454307084606\ \(0\)\
\-\ marked\\:\\ 0\\.01013641185600154\ \(0\)\
\-\ malignancy\\:\\ 0\\.010036746741038043\ \(0\)\
\-\ active\\:\\ 0\\.009916592215941886\ \(0\)\
\-\ vomiting\\:\\ 0\\.009916592215941886\ \(0\)\
\-\ 50\\:\\ 0\\.009881452938127066\ \(0\)\
\-\ radiographic\\:\\ 0\\.009858250430968794\ \(0\)\
\-\ its\\:\\ 0\\.009801007426916843\ \(0\)\
\-\ compression\\:\\ 0\\.009722636250151753\ \(0\)\
\-\ dilated\\:\\ 0\\.00943796780119036\ \(0\)\
\-\ presence\\:\\ 0\\.009427919812939603\ \(0\)\
\-\ 20\\:\\ 0\\.009338952085583635\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.009309865608330897\ \(0\)\
\-\ quadrant\\:\\ 0\\.009140960285671898\ \(0\)\
\-\ week\\:\\ 0\\.008820715557228657\ \(0\)\
\-\ masses\\:\\ 0\\.008779916103331573\ \(0\)\
\-\ three\\:\\ 0\\.008755696742695777\ \(0\)\
\-\ by\\:\\ 0\\.008649671144345743\ \(0\)\
\-\ surrounding\\:\\ 0\\.008538496244269804\ \(0\)\
\-\ differential\\:\\ 0\\.008246078508671519\ \(0\)\
\-\ between\\:\\ 0\\.008232509228645117\ \(0\)\
\-\ while\\:\\ 0\\.008172186139368733\ \(0\)\
\-\ resection\\:\\ 0\\.008100047585167839\ \(0\)\
\-\ fat\\:\\ 0\\.007899429552831712\ \(0\)\
\-\ diffuse\\:\\ 0\\.007863244438830744\ \(0\)\
\-\ as\\:\\ 0\\.007857614017593481\ \(0\)\
\-\ proximal\\:\\ 0\\.007798003591814636\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.007762999208648802\ \(0\)\
\-\ primary\\:\\ 0\\.007694177090868378\ \(0\)\
\-\ years\\:\\ 0\\.007626878835922439\ \(0\)\
\-\ wall\\:\\ 0\\.007523280000725672\ \(0\)\
\-\ level\\:\\ 0\\.007485984886464838\ \(0\)\
\-\ s\\:\\ 0\\.007449141845333091\ \(0\)\
\-\ when\\:\\ 0\\.007438696770869318\ \(0\)\
\-\ appearance\\:\\ 0\\.007428287467278545\ \(0\)\
\-\ syndrome\\:\\ 0\\.007428287467278545\ \(0\)\
\-\ distal\\:\\ 0\\.007061637048468167\ \(0\)\
\-\ significant\\:\\ 0\\.0069843378451496145\ \(0\)\
\-\ cm\\:\\ 0\\.006966431969048589\ \(0\)\
\-\ common\\:\\ 0\\.00679716477798297\ \(0\)\
\-\ abdominal\\:\\ 0\\.006492155738972995\ \(0\)\
\-\ in\\:\\ 0\\.006404213224016033\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0063833891721331824\ \(0\)\
\-\ physical\\:\\ 0\\.006372356442496165\ \(0\)\
\-\ increased\\:\\ 0\\.006354057087536947\ \(0\)\
\-\ upper\\:\\ 0\\.006267721900816773\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.006260636784140556\ \(0\)\
\-\ noted\\:\\ 0\\.006156295405630984\ \(0\)\
\-\ associated\\:\\ 0\\.006129065537713379\ \(0\)\
\-\ without\\:\\ 0\\.006115541539082554\ \(0\)\
\-\ or\\:\\ 0\\.006088284188229225\ \(0\)\
\-\ \\%\\:\\ 0\\.006058726545124643\ \(0\)\
\-\ of\\:\\ 0\\.006019953232722806\ \(0\)\
\-\ and\\:\\ 0\\.006018538185575692\ \(0\)\
\-\ mri\\:\\ 0\\.0059674038143301515\ \(0\)\
\-\ can\\:\\ 0\\.0058912533509698165\ \(0\)\
\-\ present\\:\\ 0\\.00586628800587137\ \(0\)\
\-\ this\\:\\ 0\\.00584277941224397\ \(0\)\
\-\ it\\:\\ 0\\.0058384449377903245\ \(0\)\
\-\ contrast\\:\\ 0\\.00581390786263801\ \(0\)\
\-\ exam\\:\\ 0\\.005705878236928687\ \(0\)\
\-\ may\\:\\ 0\\.0056970467139760604\ \(0\)\
\-\ case\\:\\ 0\\.0056823842944293945\ \(0\)\
\-\ large\\:\\ 0\\.005679460279121823\ \(0\)\
\-\ have\\:\\ 0\\.0056244318491340175\ \(0\)\
\-\ findings\\:\\ 0\\.005528379744042431\ \(0\)\
\-\ the\\:\\ 0\\.005462737693456338\ \(0\)\
\-\ surgical\\:\\ 0\\.005459640639062169\ \(0\)\
\-\ lesion\\:\\ 0\\.005290441416414756\ \(0\)\
\-\ seen\\:\\ 0\\.0051326067327285415\ \(0\)\
\-\ on\\:\\ 0\\.004400553266659137\ \(0\)\
\-\ \\(\\:\\ 0\\.004391256694491553\ \(0\)\
\-\ \\)\\:\\ 0\\.004337615149624955\ \(0\)\
\-\ be\\:\\ 0\\.0040053395846320035\ \(0\)\
\-\ ct\\:\\ 0\\.0036331418036232308\ \(0\)\
\-\ a\\:\\ 0\\.0036164115667349657\ \(0\)\
\-\ mass\\:\\ 0\\.00361234348616281\ \(0\)\
\-\ history\\:\\ 0\\.0035872782301127155\ \(0\)\
\-\ pain\\:\\ 0\\.0031720612994855157\ \(0\)\
\-\ left\\:\\ 0\\.0029060950433827193\ \(0\)\
\-\ old\\:\\ 0\\.0026593756743533573\ \(0\)\
\-\ no\\:\\ 0\\.002615331765057149\ \(0\)\
\-\ to\\:\\ 0\\.002596158713939126\ \(0\)\
\-\ for\\:\\ 0\\.0022161341904033895\ \(0\)\
\-\ with\\:\\ 0\\.001778178967931455\ \(0\)\
\-\ \\.\\:\\ 0\\.0016185198828577328\ \(0\)\
